Main Category: Conferences
Article Date: 01 May 2012 - 7:00 PDT
Patient / Public:
Healthcare Prof: Payer public health investment priorities to stimulate the development of value-adding anti-cancer medicines
This will be a very unique conference that will allow public and private payers (i.e. health plans, Medicare, Medicaid, PBMs, HTA agencies, policy makers in the USA and internationally) and oncology healthcare providers to come together to present and discuss their views regarding their current and future unmet needs in oncology indications . This discussion will help bring fresh insight discussion amongst key stakeholders to prevent the wasted development of "me-too" drugs in the coming years, and to encourage investment into therapies for indications that achieve budget-effective medical "innovation" and improve patient access to high-value medications. The event will also look at what the biopharma industry needs to do to integrate payer unmet needs into cancer RD pipelines and generate clearer evidence of added-value, by hitting payer-focused endpoints and to develop advanced medications that improve real health outcomes.
Why attend?
- Understand what global payers define as "unmet need" and drug "value" for anti-cancer medications
- Realise what is meant by "innovation" in oncology and how much this should be rewarded
- Learn how health technology assessments are made in oncology and what evidence is required
- Discover how comparative effectiveness research in cancer has been working in real-life
- Appreciate what steps drug developers are making to integrate payer-focused endpoints into clinical trials and enhancing real-world evidence generation
- Determine how the pharma biotech industry are reengineering RD portfolios to satisfy payers needs for budget-effective anti-cancer therapies
Conference Dates: 6-7 August 2012
Venue: Philadelphia, USA
Agenda request
To request the full agenda please follow this link.
For Booking Information contact:
Erika Vavrovicova
Tel: +421 232 660 382
Fax: +421 2 3301 0331
Email: erika@nextlevelpharma.com
Visit: http://www.nextlevelpharma.com
- Additional
- References
- Citations
MLA
APA
Please note: If no author information is provided, the source is cited instead.
Add Your Opinion On This Article
'Oncology Unmet Medical Need Forum, 6-7 August 2012, Philadelphia, USA'Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy | Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
Tidak ada komentar:
Posting Komentar